FDA Inspection 1018450 — James L. Campbell Jr, MD
The FDA completed an inspection of James L. Campbell Jr, MD on Jun 14, 2017 in Portsmouth, NH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Portsmouth, NH (United States)
Additional details
Clinical Investigator (CI)